Piperidine glycine transporter inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 24, 2011
Grant Date -
Oct 29, 2009
app pub date -
Oct 27, 2006
filing date -
Oct 28, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully